Carregant...

Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options

Background: Gaucher disease is a rare lysosomal storage disease resulting from a deficiency or reduced activity in the acid β-glucocosidase enzyme. Only 1 treatment option was available for 15 years, but several new treatment options have come to market since 2003. Objective: The article will detail...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hosp Pharm
Autors principals: Van Rossum, Alison, Holsopple, Megan
Format: Artigo
Idioma:Inglês
Publicat: Thomas Land Publishers, Inc. 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4981103/
https://ncbi.nlm.nih.gov/pubmed/27559188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5107-553
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!